Very recently, in NAFLD patients, an activation of miR-34a/SIRT1/p53 pathway has been described to be correlated with the degree of the disease from steatosis to more severe NASH [55]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.